ArticleMolecular cancer therapeutics2019

Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.

Saif Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.